Abiopharma

News list

Director Hyten John E. 🟡 adjusted position in 0 shares of C3.ai, Inc. (AI) Transaction Date: Mar 31, 2026 | Filing ID: 000038

Full text

News bot April 1, 2026, 10:49 p.m.
🔍 Hyten John E. (Director)

Company: C3.ai, Inc. (AI)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 43,944
- Total shares sold: 43,944
Detailed Transactions and Holdings:
- Sold 43,944 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: G | equity_swap_involved: 0 | shares_owned_after: 79,214.00 | transaction_form_type: 4
- Acquired 43,944 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: G | equity_swap_involved: 0 | shares_owned_after: 146,830.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares are held by the Hyten Group LLC, of which the Reporting Person is the manager and sole member.